VALPROIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Valproic, and when can generic versions of Valproic launch?
Valproic is a drug marketed by Bionpharma, Catalent, Chartwell Rx, Hibrow Hlthcare, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Ani Pharms, Hikma, Lannett Co Inc, Pai Holdings, Pharm Assoc, Pharmobedient Cnsltg, and Quagen. and is included in fifteen NDAs.
The generic ingredient in VALPROIC is valproic acid. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valproic
A generic version of VALPROIC was approved as valproic acid by CATALENT on October 29th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VALPROIC?
- What are the global sales for VALPROIC?
- What is Average Wholesale Price for VALPROIC?
Summary for VALPROIC
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for VALPROIC |
| DailyMed Link: | VALPROIC at DailyMed |


